Molecular Pharmaceutics

Molecular Pharmaceutics

分子药剂学

  • 2区 中科院分区
  • Q1 JCR分区

期刊简介

《Molecular Pharmaceutics》是由American Chemical Society出版社于2004年创办的英文国际期刊(ISSN: 1543-8384,E-ISSN: 1543-8392),该期刊长期致力于药学领域的创新研究,主要研究方向为医学-药学。作为SCIE收录期刊(JCR分区 Q1,中科院 2区),本刊采用OA开放获取模式(OA占比0.0308...%),以发表药学领域等方向的原创性研究为核心(研究类文章占比90.00%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在460篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Molecular Pharmaceutics审稿周期约为 约2.0个月 。该刊近年未被列入国际预警名单,年发文量约460篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 460 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
PHARMACOLOGY & PHARMACY 药学 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
2区 3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验 PHARMACOLOGY & PHARMACY 药学
2区 2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 52 / 189

72.8%

学科:PHARMACOLOGY & PHARMACY SCIE Q1 60 / 354

83.2%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q1 37 / 189

80.69%

学科:PHARMACOLOGY & PHARMACY SCIE Q1 56 / 354

84.32%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:8 SJR:0.94 SNIP:0.981
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmaceutical Science Q1 31 / 183

83%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Drug Discovery Q1 36 / 157

77%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Molecular Medicine Q2 51 / 178

71%

期刊发文

  • Targeted Nanodrugs to Destroy the Tumor Extracellular Matrix Barrier for Improving Drug Delivery and Cancer Therapeutic Efficacy

    Author: Chen, Minglong; Chen, Bin; Ge, Xiaoguang; Ma, Qingjie; Gao, Shi

    Journal: MOLECULAR PHARMACEUTICS. 2023; Vol. 20, Issue 5, pp. 2389-2401. DOI: 10.1021/acs.molpharmaceut.2c00947

  • Longitudinal MicroSPECT Imaging of Systemic Sclerosis Model Mice with [99mTc]Tc-HYNFA via Folate Receptor Targeting

    Author: Zhang, Yiren; Wen, Xuejun; Wang, Yanjie; Yang, Xia; Chen, Yingxi; Zeng, Xinying; Li, Yesen; Huang, Jinxiong; Guo, Zhide; Zhang, Xianzhong

    Journal: MOLECULAR PHARMACEUTICS. 2023; Vol. 20, Issue 1, pp. 473-480. DOI: 10.1021/acs.molpharmaceut.2c00717

  • Novel Oxygen-Dependent Degradable Immunotoxin Regulated by the Ubiquitin-Proteasome System Reduces Nonspecific Cytotoxicity

    Author: Wei, Min; Chen, Anxiang; Zhang, Jian; Ren, Yuhong

    Journal: MOLECULAR PHARMACEUTICS. 2023; Vol. 20, Issue 1, pp. 90-100. DOI: 10.1021/acs.molpharmaceut.2c00503

  • ICG-Dimeric Her2-Specific Affibody Conjugates for Tumor Imaging and Photothermal Therapy for Her2-Positive Tumors

    Author: Jia, Dianlong; Liu, Huimin; Zheng, Shuhui; Yuan, Dandan; Sun, Ruohan; Wang, Fei; Li, Yang; Li, Hui; Yuan, Fengjiao; Fan, Qing; Zhao, Zhenxiong

    Journal: MOLECULAR PHARMACEUTICS. 2023; Vol. 20, Issue 1, pp. 427-437. DOI: 10.1021/acs.molpharmaceut.2c00708

  • Myricetin-Loaded Nanomicelles Protect against Cisplatin-Induced Acute Kidney Injury by Inhibiting the DNA Damage-cGAS-STING Signaling Pathway

    Author: Qi, Xueju; Wang, Jing; Fei, Fengshu; Gao, Xintao; Wu, Xiaochen; Shi, Dayong; Guo, Chuanlong

    Journal: MOLECULAR PHARMACEUTICS. 2023; Vol. 20, Issue 1, pp. 136-146. DOI: 10.1021/acs.molpharmaceut.2c00520

  • Engineered Fenofibrate as Oxidation-Sensitive Nanoparticles with ROS Scavenging and PPAR alpha-Activating Bioactivity to Ameliorate Nonalcoholic Fatty Liver Disease

    Author: Du, Kaiyue; Huang, Xin; Peng, Ankang; Yang, Qinghua; Chen, Du; Zhang, Jianxiang; Qi, Rong

    Journal: MOLECULAR PHARMACEUTICS. 2023; Vol. 20, Issue 1, pp. 159-171. DOI: 10.1021/acs.molpharmaceut.2c00549

  • Unsaturated Fatty Acid Liposomes Selectively Regulate Glutathione Peroxidase 4 to Exacerbate Lipid Peroxidation as an Adaptable Liposome Platform for Anti-Tumor Therapy

    Author: Huang, Huan; Chen, Yuling; Yin, Na; Li, Gaojie; Ye, Shanshan; Guo, Ling; Feng, Min

    Journal: MOLECULAR PHARMACEUTICS. 2023; Vol. 20, Issue 1, pp. 290-302. DOI: 10.1021/acs.molpharmaceut.2c00642

  • 18F-5-FPN: A Specific Probe for Monitoring Photothermal Therapy Response in Malignant Melanoma

    Author: Wang, Yichun; Li, Mengting; Zhang, Xiao; Ji, Hao; Wang, Wenxia; Han, Na; Li, Huiling; Xu, Xiaodong; Lan, Xiaoli

    Journal: MOLECULAR PHARMACEUTICS. 2023; Vol. 20, Issue 1, pp. 572-581. DOI: 10.1021/acs.molpharmaceut.2c00742